What does the future hold for wearable device-derived health data? According to Debra Michaels, a Senior Scientist at DIA Americas:
"It is likely that efforts to reduce barriers to the use of mobile technologies in clinical studies will intensify in the near future. Aside from the potential benefits they may bring to clinical trials, their post-market applications, such as assessment of safety and effectiveness of therapies and improvement of quality of care through data for better patient and shared decision making, are important drivers for adoption of these technologies. The biggest driver of all may be patients, who have embraced mobile technology and expect it to keep improving their lives."
To learn more about the application of wearable derived data in clinical trials, check out Debra Michaels' full piece published by Clinical Leader.
Subscribe to the MMIT blog for more pharma, provider, and payer perspectives on key topics that affect the healthcare network.